Option chain shows key data for Dermata Therapeutics's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Dermata Therapeutics.

Dermata Therapeutics (NASDAQ:DRMA) Stock, Option Chain

Dermata Therapeutics

Dermata Therapeutics Inc. is a clinical-stage medical dermatology company focused on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin conditions and diseases. Its two product candidates, DMT310 and DMT410, incorporate its proprietary, multifaceted, Spongilla technology to topically treat a variety of dermatological conditions. Its Spongilla technology platform will enable to development and formulation of singular and combination products that can target topical delivery of chemical compounds into the dermis for maximum treatment effect for a variety of inflammatory skin diseases.

New,York,-,May,22:,New,York,Stock,Exchange,May

Equities

Government

Market Summary

News

Futures

Treasuries

Economics

Federal Reserve

Pre-Market Outlook

Markets

Analyst Ratings

Trading Ideas

ETFs

BRZE

DBVT

DRCT

DRMA

KPLT

LULU

MERCEDES BENZ GROUP AG by Mercedes Benz Group AG

MBGAF

Porsche Automobil Holding SE Stuttgart Pref No VTG RTS

POAHF

SNSE

VRNT

XTIA

U.S. stock futures fell on Friday after two consecutive days of decline on Wednesday and Thursday. Futures of benchmark indices were lower.

US Stocks Likely To Open Lower, Analysts Warn &#39;Prolonged Uncertainty Could Hurt Both US And Global Risk Assets&#39;

Lululemon, Applovin Corp, Hertz, Rivian, Tesla: Why These 5 Stocks Are On Investors' Radars Today

Movers

ALTG

ASTI

KULR

LGMK

MERC

PAPL

PRLD

PRTG

PTIX

RNAZ

STSS

Why Braze Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket

Macro,View,Of,Stacks,Of,Gold,Bars

Earnings

Eurozone

Commodities

Intraday Update

AUUD

GTEC

SLNO

Gold Gains Over 1%; TD SYNNEX Shares Plunge After Downbeat Results

Dermata Therapeutics, Inc. - Common Stock

Dermata Therapeutics Inc

Offerings

Press Releases

Dermata Therapeutics Announces $2.55 Million Private Placement Priced At-The-Market Under Nasdaq Rules

Dermata Therapeutics Announces Closing of $2.55 Million Private Placement Priced At-The-Market Under Nasdaq Rules

Dermata Expands Patent Portfolio with Issuance of New U.S. Patent for Next-Generation Acne Treatment

Dermata to Present on BioPub on January 31, 2025

Dermata Receives Notice of Acceptance of Australian Patent Application for Topical Botulinum Toxin Treatment for Hyperhidrosis

Dermata Announces that Last Patient Completes Last Visit in Pivotal XYNGARI™ Phase 3 STAR-1 Clinical Trial for Acne

Dermata Therapeutics Provides Corporate Update and Reports Year End 2024 Financial Results

BREAKING: Dermata's XYNGARI™ Phase 3 Trial Topline Data Meets All Primary Endpoints

Dermata Therapeutics Announces Exercise of Warrants for $6.2 Million in Gross Proceeds Priced At-the-Market Under Nasdaq Rules

Dermata's XYNGARI(TM) Phase 3 Trial Hits Statistically Significant Difference at 4 Weeks

DRMAW

AEON Biopharma, Inc. Class A Common Stock

AEON Biopharma

Alzamend Neuro

180 Life Sciences

Azitra

Brainstorm Cell Therapeutics Inc. - Common Stock

Brainstorm Cell

Biodexa Pharmaceuticals plc - American Depositary Shares

Biodexa Pharmaceuticals

Creative Medical Technology Holdings, Inc. - Common Stock

Creative Medical Tech

CERo Therapeutics Holdings, Inc. - Common Stock

CERo Therapeutics Hldgs

Cyclacel Pharmaceuticals, Inc. - Common Stock

Cyclacel Pharmaceuticals

Galecto

Klotho Neurosciences, Inc. - Common Stock

Klotho Neurosciences

Pasithea Therapeutics Corp. - Common Stock

Pasithea Therapeutics

Lixte Biotechnology Holdings, Inc. - Common Stock

Lixte Biotechnology

Mustang Bio

Oragenics

Palisade Bio

Palatin Techs

Sunshine Biopharma

SILO Pharma

Sonnet BioTherapeutics Holdings, Inc. - Common Stock

Sonnet BioTherapeutics

Alaunos Therapeutics, Inc. - Common Stock

Alaunos Therapeutics

Theriva Biologics

Windtree Therapeutics, Inc. - Common Stock

Windtree Therapeutics

Longevity Health Holdings, Inc. - Common Stock

Longevity Health Holdings

Xenetic Biosciences

Maxim Group

Comments

Dermata Therapeutics

Dermata Therapeutics (DRMA) Options

No option chain data available. Please try again later

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell